Treatment of Infection and Colonization Caused by Methicillin-Resistant Staphylococcus aureus
- 1 January 1991
- journal article
- review article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 12 (1), 29-35
- https://doi.org/10.1086/646235
Abstract
The mechanism of methicillin resistance confers resistance to all available B-lactam antibiotics; consequently, B-lactam antibiotics have no role in therapy of methicillin-resistant Staphylococcus aureus (MRSA) infections. Vancomycin remains the drug of choice. Teicoplanin and daptomycin are two investigational antibiotics related to vancomycin in structure and in spectrum of activity. In clinical trials employing relatively low doses, neither was as effective as vancomycin. Trials at higher doses are on-going. Quinolones, ciprofloxacin in particular, have been used successfully to treat infections caused by MRSA; however, the usefulness of quinolones may be limited by the tendency of resistance to emerge during therapy. Quinolones probably should be used only in combination with another active agent, such as rifampin, when treating serious infections caused by MRSA. Other agents may be active in vitro against MRSA, but clinical data showing their effectiveness are lacking. Rifampin combination regimens appear most effectively to eradicate colonization with MRSA.Keywords
This publication has 61 references indexed in Scilit:
- Binding of -Lactam Antibiotics to Penicillin-Binding Proteins in Methicillin-Resistant Staphylococcus aureusThe Journal of Infectious Diseases, 1990
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- Endocarditis Due to Methicillin-Resistant Staphylococcus aureus in Rabbits: Expression of Resistance to -Lactam Antibiotics in Vivo and in VitroThe Journal of Infectious Diseases, 1984
- Vancomycin Treatment of Bacteremia Caused by Oxacillin-Resistant Staphylococcus aureus: Comparison with -Lactam Antibiotic Treatment of Bacteremia Caused by Oxacillin-Sensitive Staphylococcus aureusThe Journal of Infectious Diseases, 1983
- Single and Combination Antibiotic Therapy of Staphylococcus aureus Experimental Endocarditis: Emergence of Gentamicin-Resistant MutantsAntimicrobial Agents and Chemotherapy, 1978
- Failure of Vancomycin Treatment in Staphylococcus aureus EndocarditisJAMA, 1976
- Methicillin-ResistantStaphylococcus aureusat Boston City HospitalNew England Journal of Medicine, 1968